Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alex azar
alirocumab
alnylam pharmaceuticals
ambys medicines
american patients first
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
biomarin pharmaceutical
biosimilars
biotech
What
drug
drugs
long
2
×
prices
2
×
afternoon
anticipated
aren’t
awaited
bio
blueprint
cost
cut
details
developers
fda
gene
help
house
imminent
lower
meant
medicare
moves
news
noteworthy
patients
plan
pledges
prescription
president
road
roundup
rulings
separate
short
speech
therapy
they’ll
trump
unveiled
Language
Current search:
prices
×
long
×
" regeneron pharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
